Doctors keep saying OBLs aren’t worth it anymore — so why is private equity betting big on them?
Many physicians believe the golden years of OBLs are behind us. Margins are tighter, regulations are stricter, and the risks seem higher. But private equity firms see something different—opportunity. The problem isn’t the model itself, it’s inefficiency.
Dr. Rundback breaks down why strategic efficiency — not abandoning ship — is the key to long-term success. If you’re in the OBL space or considering it, this conversation is one you can’t afford to miss.
Go to the Life of Flow podcast channel and watch the full episode #56!
